Library
PubMed
research article
Professional

Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry.

Source: PubMed, NCBI / U.S. National Library of Medicine

CancersKawaji Yuki, Yamao Kentaro, Ashida Reiko, et al.Published 5/22/2026Last synced 6/14/2026Status: syncedPMID: 42279269DOI: 10.3390/cancers18111684

Pancreatic cancer (PC) should be diagnosed in its early stages. Therefore, it is necessary to identify high-risk individuals of PC. Between 2001 and 2017, 1542 PC cases were diagnosed at two tertial care institutions. Of these, 117 cases had undergone abdominal contrast-enhanced computed tomography (CE-CT) 1-10 years before PC diagnosis and were classified as the PC group. Meanwhile, 43,102 cases underwent abdominal CE-CT for close examination of non-pancreatic diseases in the same period, of which 1170 were randomly selected. Of these, 117 cases were matched to the PC group with the propensity score and designated the non-PC group. Pancreatic volumetry was performed using the 3D image analysis system for abdominal CE-CT in both groups and various measurements were compared. In PC group, CE-CT taken 1-10 years before the onset of PC was analyzed. After propensity score matching, baseline characteristics did not significantly differ between the two groups. The whole pancreatic volume/body surface area (BSA) (= 0.014), volume of main pancreatic duct (MPD) plus cystic lesion/BSA (< 0.001), volume of pancreatic parenchyma/BSA (= 0.002), ratio of cross-sectional areas (= 0.033), and MPD diameter/BSA (< 0.001) significantly differed between the two groups. In subgroup analysis of patients without cystic lesions, the whole pancreatic volume/BSA, volume of MPD/BSA, volume of pancreatic parenchyma/BSA, ratio of cross-sectional areas, and MPD diameter/BSA significantly differed between

Abstract

Pancreatic cancer (PC) should be diagnosed in its early stages. Therefore, it is necessary to identify high-risk individuals of PC. Between 2001 and 2017, 1542 PC cases were diagnosed at two tertial care institutions. Of these, 117 cases had undergone abdominal contrast-enhanced computed tomography (CE-CT) 1-10 years before PC diagnosis and were classified as the PC group. Meanwhile, 43,102 cases underwent abdominal CE-CT for close examination of non-pancreatic diseases in the same period, of which 1170 were randomly selected. Of these, 117 cases were matched to the PC group with the propensity score and designated the non-PC group. Pancreatic volumetry was performed using the 3D image analysis system for abdominal CE-CT in both groups and various measurements were compared. In PC group, CE-CT taken 1-10 years before the onset of PC was analyzed. After propensity score matching, baseline characteristics did not significantly differ between the two groups. The whole pancreatic volume/body surface area (BSA) (= 0.014), volume of main pancreatic duct (MPD) plus cystic lesion/BSA (< 0.001), volume of pancreatic parenchyma/BSA (= 0.002), ratio of cross-sectional areas (= 0.033), and MPD diameter/BSA (< 0.001) significantly differed between the two groups. In subgroup analysis of patients without cystic lesions, the whole pancreatic volume/BSA, volume of MPD/BSA, volume of pancreatic parenchyma/BSA, ratio of cross-sectional areas, and MPD diameter/BSA significantly differed between the two groups. Pancreatic volumetry could identify patients at high risk of PC.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.